INTRODUCTION
Axonal targeting of membrane proteins controlling guidance, adhesion, neuronal survival, and synaptic connectivity is a critical determinant in the establishment of neuronal circuits during development. After synthesis in neuronal soma, delivery of membrane proteins to axons has been proposed to occur via several modes, including direct transport after sorting at the trans-Golgi network, non-polarized delivery to axons and dendrites followed by selective retention in axons, or transcytosis where initial delivery of newly synthesized membrane proteins to somato-dendritic compartments is followed by endocytosis and anterograde transport (Horton and Ehlers, 2003; Winckler and Mellman, 2010) . Discrete steps in the axonal targeting process, including exit from neuronal soma, anterograde trafficking along microtubules, and local insertion into growth cones, present regulatory nodes for precise control of surface receptor levels in response to cell-extrinsic factors or neuronal activity. Ligand-mediated local insertion of guidance and trophic receptors has been documented in growth cones (Bouchard et al., 2004; Dequidt et al., 2007; Du et al., 2000; Tojima et al., 2007) . However, whether, and how, extracellular cues impinging on axon terminals can influence the long-range anterograde delivery of signaling receptors from neuronal cell bodies has been poorly defined.
The family of neurotrophins provides one of the best examples of target-derived diffusible cues that govern neuron survival, target innervation, and synaptic plasticity in the vertebrate nervous system (Huang and Reichardt, 2001 ). The prototypical neurotrophin, nerve growth factor (NGF), is essential for neuron viability and axon growth of select neuronal populations in the peripheral nervous system during development, and is also a critical mediator of inflammatory pain during adulthood (Sofroniew et al., 2001 ). Since NGF is produced by target fields of peripheral neurons, a key mode of NGF action is ligand binding to TrkA receptors at axon terminals followed by receptor endocytosis and long-distance retrograde transport of NGF-TrkAcontaining signaling endosomes back to neuronal cell bodies (Yamashita and Kuruvilla, 2016) . Receptor internalization in distal axons and retrograde transport must be balanced by anterograde targeting of newly synthesized receptors to ensure continued responses to target-derived ligand. Compared with the intense focus on retrograde trafficking of Trk receptors, relatively little is known about their anterograde delivery. Limited studies conducted so far favor the model of constitutive Trk transport through the secretory pathway and have shed some light on the molecular components involved, including sortilin, a Vps10 domain family member that regulates receptor sorting at the Golgi apparatus (Vaegter et al., 2011) , the plus-end directed motors, KIF1A and kinesin-1 (Arimura et al., 2009; Tanaka et al., 2016) , and an adaptor complex consisting of the Rab27 GTPase, its effector, Slp1, and CRMP-2, a microtubule-binding protein (Arimura et al., 2009) .
Recent studies suggest that ligand-triggered signaling at axon terminals also plays a critical role in recruiting neurotrophin receptors to axons (Ascano et al., 2009; Cheng et al., 2011) . In particular, in sympathetic neurons, TrkA receptors are transported to axons by transcytosis, where receptors embedded in the plasma membrane of neuronal soma are endocytosed and re-directed to axons via Rab11-positive recycling endosomes (Ascano et al., 2009) . Anterograde TrkA transcytosis is necessary for optimal signaling and growth responses to NGF, and intriguingly, is augmented by NGF itself acting on distal axons. These findings suggest a trafficking-based positive feedback mechanism that enhances neuronal sensitivity to limiting concentrations of target-derived neurotrophin. However, how NGF acting at axon terminals promotes the long-range anterograde trafficking of its receptors remains unknown. Here, using compartmentalized cultures of sympathetic neurons and genetic mouse models, we reveal that retrograde NGF-TrkA signaling endosomes are necessary for anterograde transcytosis of TrkA receptors and identify an ER-associated dephosphorylation mechanism that ensures delivery of inactive receptors to axon terminals.
RESULTS

Retrograde Transport of Trk Receptors Is Necessary for Anterograde Transcytosis
How is the retrograde NGF signal, initiated in distal axons, relayed to naive TrkA receptors resident on soma surfaces to mediate anterograde transcytosis? Retrograde communication of NGF trophic signaling occurs via ligand-triggered endocytosis of TrkA receptors in axon terminals and retrograde trafficking of NGF-TrkA signaling endosomes back to cell bodies (Yamashita and Kuruvilla, 2016) . To address if NGF-TrkA endosomes are necessary for soma-to-axon transcytosis, we first asked whether Trk tyrosine kinase activity in distal axons, a prerequisite step in initiating retrograde neurotrophin signaling (Kuruvilla et al., 2000) , is necessary for anterograde transport. To visualize transcytosis of Trk receptors originating from soma surfaces, we employed a chimeric Trk receptor-based live-cell antibody feeding assay in compartmentalized cultures of sympathetic neurons ( Figure 1A ) (Ascano et al., 2009 ). Neurons were infected with an adenoviral vector that expresses FLAG-tagged chimeric receptors that have the extracellular domain of TrkB and transmembrane and intracellular domains of TrkA (FLAG-TrkB:A). Sympathetic neurons do not normally express TrkB receptors, and chimeric Trk receptors respond to the TrkB ligand, brain-derived neurotrophic factor (BDNF), but retain the signaling properties of TrkA (Ascano et al., 2009) . Infected neurons were identified by GFP fluorescence where GFP was co-expressed with FLAG-TrkB:A receptors using a self-cleaving 2A peptide sequence. Surface chimeric receptors were live-labeled with anti-FLAG antibody exclusively in cell-body compartments. BDNF stimulation of axons (100 ng/mL, 4 hr) significantly increased the intracellular accumulation of FLAG antibody-bound TrkB:A receptors originating from neuronal soma surfaces in cell bodies and also promoted their anterograde transport to axons, as revealed by labeling with a fluorescent secondary antibody ( Figures 1A-1C, 1H , and 1I), and consistent with our previous findings (Ascano et al., 2009 ). These results indicate that ligand, acting on distal axons, first triggers the internal accumulation of soma-surfacederived Trk receptors that are then anterogradely transported to distal axons via transcytosis. To address if Trk receptor kinase activity in distal axon compartments is required for anterograde transcytosis, we took advantage of a F592A mutation in FLAG-TrkB:A receptors that renders them sensitive to a small-molecule membrane-permeable inhibitor, 1NMPP1 (Chen et al., 2005) . Addition of 1NMPP1 (100 nM) to distal axons of compartmentalized neurons suppressed the BDNF-induced intracellular accumulation in cell bodies and anterograde transport of FLAG-bound Trk receptors ( Figures 1A-1D, 1H , and 1I). These results indicate that Trk receptor activation and initiation of retrograde neurotrophin signaling in distal axons is necessary for the intracellular accumulation of soma-surface-derived receptors and their anterograde transport.
Previously, we reported that NGF-induced TrkA endocytosis in sympathetic axons depends on TrkA-mediated recruitment of phospholipase C-g (PLC-g), which then stimulates calcineurin, a calcium-dependent phosphatase, to dephosphorylate the endocytic GTPase, dynamin1 (Bodmer et al., 2011) . To further probe the retrograde Trk signaling mechanisms that mediate transcytosis, we sought to interfere with Trk receptor endocytosis in distal axons. We added specific pharmacological inhibitors of the PLC-g-calcineurin-dynamin endocytic pathway to distal axons in compartmentalized cultures and monitored the transcytosis of soma-surface-derived Trk receptors using FLAG antibody feeding. We found that ligand-induced Trk internalization in cell bodies and anterograde transport was completely abrogated by addition of a PLCg inhibitor (U73122, 10 mM), the calcineurin phosphatase inhibitors (FK506, 0.2 mg/mL + cyclosporin A, 2 mg/mL), or dynasore (80 mM), an inhibitor of dynamin-mediated endocytosis, to axon compartments ( Figures 1A and 1E-1I ). These results indicate that Trk receptor endocytosis initiated in distal axons is necessary for soma-to-axon transcytosis.
Axon-and Soma-Surface-Derived Trk Receptors Interact in Neuronal Soma
We next asked how the retrograde transport of active TrkA receptors influences anterograde transcytosis. Previously, retrogradely transported signaling endosomes have been observed to recycle between the soma cell surface and interior upon reaching cell bodies (Suo et al., 2014) . Thus, one plausible mechanism for interactions between axon-and soma-surface-derived receptor populations is that retrogradely transported TrkA receptors are exocytosed to the soma membrane, bringing them in close proximity to resident naive receptors. To visualize exocytosis of retrogradely transported receptors in soma, we performed a modified FLAG feeding assay where surface Trk receptors in axons, live-labeled with anti-FLAG antibody and retrogradely transported, were detected on soma surfaces of non-permeabilized neurons using a fluorescent secondary antibody ( Figure 2A ). We found that, compared with unstimulated neurons, BDNF treatment of distal axons elicited a 4-fold increase in FLAG punctae that appeared on soma surfaces (3 ± 0.48 FLAG punctae per neuron in unstimulated conditions versus 13 ± 1 with BDNF treatment) ( Figures 2B-2D ). Because antibody-tagged receptors could only have originated from axonal surfaces, these results provide direct evidence for insertion of retrogradely transported Trk receptors on soma surfaces in response to ligand stimulation of distal axons.
We next asked if we could visualize retrogradely transported Trk receptors in close proximity to soma-surface-derived receptors. Thus, we performed dual-color FLAG antibody feeding in compartmentalized neurons, where axon and soma-surface Trk receptors were live-labeled with mouse and rabbit anti-FLAG antibodies, respectively ( Figure 2E ). After stimulating axons with BDNF for 1 hr to promote retrograde Trk transport, neurons were fixed and incubated with anti-mouse Alexa 546 and anti-rabbit Alexa 350 secondary antibodies to detect retrogradely transported and soma-surface-resident receptors, respectively. In the absence of ligand, soma-surface-resident Trk receptors were observed at the plasma membrane, and there was little retrograde accumulation of axonal Trk receptors, as expected ( Figures 2F-2H ). In contrast, ligand treatment of distal axons elicited retrograde appearance of axonal Trk receptors that co-localized with soma-surface-derived receptors at the cell periphery ( Figures 2I-2L ). Quantification revealed that 49.5% ± 3.2% of soma-surface-derived FLAG-TrkB:A receptors co-localize with axon-derived receptors, suggesting that a significant fraction of soma-surface-derived Trk receptors encounter retrogradely transported receptors in cell bodies. We next asked if these two receptor populations are capable of associating with each other. Thus, we performed an in situ proximity ligation assay (PLA) where interactions between axon-and soma-surface-derived FLAG-TrkB:A receptors can be visualized as discrete fluorescent spots using a DNA ligation and rolling circle amplification strategy (Soderberg et al., 2006) . We observed a significant increase in interactions between the axon-and soma-surface-derived receptors, primarily at the cell surface, upon ligand stimulation (2 ± 0.56 PLA punctae per neuron in unstimulated conditions versus 10.6 ± 1.4 with BDNF treatment) ( Figures 2M and 2N ). PLA signals were rarely detected intracellularly suggesting that receptor interactions at the soma plasma membrane are transient. Since the in situ PLA cross-links proteins that are <40 nm apart, these results suggest that retrogradely transported active Trk receptors dimerize with naive resident receptors at the soma surface. We next sought to address the outcome of interactions between axon-derived active Trk receptors and naive somasurface receptors. Exocytosis of retrograde Trk signaling endosomes could elicit phosphorylation of naive cell-surfaceresident receptors, either by locally increasing receptor density and transient receptor dimerization in membrane microdomains and/or via extracellular release of ligand that is cotransported in signaling endosomes. To address whether soma-surface Trk receptors undergo phosphorylation in a manner dependent on retrograde neurotrophin signaling, we employed a cell-surface biotinylation assay where surface proteins in cell-body chambers of compartmentalized cultures were biotin-labeled, followed by NGF stimulation of axons (100 ng/mL, 1 hr). Cell-body lysates were subjected to neutravidin precipitation and immunoblotting with an anti-phospho-TrkA antibody (P-TrkA Y794 ) ( Figure 2O ). NGF stimulation of sympathetic axons resulted in a striking increase in phosphorylation of TrkA receptors derived from the soma surface (Figures 2P and 2Q) . Since surface proteins in cell-body chambers were biotinylated before adding NGF to axons, these results imply that the Trk receptors being phosphorylated in a manner dependent on retrograde NGF signaling were resident on soma surfaces prior to the initiation of retrograde transport.
Together, these results suggest that surface insertion of retrogradely transported active TrkA receptors in neuronal cell bodies elicits the phosphorylation of neighboring naive receptors, which is necessary to promote endocytosis of receptors destined for anterograde transcytosis.
PTP1B, an ER-Resident Phosphatase, Dephosphorylates Endocytosed Trk Receptors in Soma
Previous observations of axonal transport of phosphorylated Trk receptors have noted that active receptors are exclusively trafficked in the retrograde, but not anterograde, direction (Bhattacharyya et al., 2002; Ye et al., 2003) . If Trk receptors destined for transcytosis are phosphorylated in cell bodies, a key question then is how are these receptors inactivated prior to anterograde transport? Thus, we reasoned that a tyrosine phosphatase activity must exist in the soma to dephosphorylate Trk receptors prior to axonal targeting. In searching for candidate phosphatases, a clue came from previous findings that PTP1B, an ER-resident tyrosine phosphatase with its catalytic domain on the cytosolic face, dephosphorylates active receptor tyrosine kinases (RTKs) harbored in endosomes as they transit past the ER (Stuible and Tremblay, 2010) . Trk receptors harbor a putative PTP1B substrate recognition motif in their tyrosine kinase domain, and PTP1B associates with active TrkB receptors (Krishnan et al., 2015; Ozek et al., 2014 ).
PTP1B's interactions with its substrates are transient, and stable PTP1B-substrate complexes can only be detected by using substrate-trapping PTP1B variants (Haj et al., 2002) . We found that FLAG-TrkA associates with Myc-tagged PTP1B Y46F/D181A and PTP1B C215S ( Figure S1A ), both of which function as substrate-trapping variants (Ozek et al., 2014) , using co-immunoprecipitation analyses in HEK293T cells. PTP1B Y46F/D181A exhibited stronger binding for TrkA compared with PTP1B
C215S
( Figure S1A ), consistent with previously reported interactions for TrkB (Ozek et al., 2014) . Importantly, when we expressed PTP1B WT , this suppressed the tyrosine auto-phosphorylation of TrkA elicited by receptor overexpression in heterologous cells, as detected by FLAG immunoprecipitation and immunoblotting with a pan anti-phosphotyrosine antibody (pY20 Figure 3A ), indicating that this association is dependent on ligand-induced activation of TrkA receptors in primary neurons. NGF-induced TrkA tyrosine phosphorylation, detected using an anti-P-TrkA Y794 antibody, was diminished by adenovirus-mediated overexpression of PTP1B WT ( Figures 3B and 3C ). In contrast, expression of PTP1B Y46F/D181A mutant, which has reduced catalytic activity, enhanced tyrosine phosphorylation of TrkA ( Figures 3B and 3C ), suggesting that this mutant likely functions in a dominantnegative manner. Together, these results provide evidence that PTP1B binds to activated TrkA receptors resulting in their dephosphorylation.
PTP1B acts on RTKs after endocytosis (Haj et al., 2002) , or at sites of direct ER contact with the plasma membrane at regions of cell-cell contact (Eden et al., 2010; Haj et al., 2012) . To address where in sympathetic neurons soma-surface-derived Trk receptors encounter PTP1B, we performed FLAG antibody feeding in compartmentalized cultures infected with adenoviruses expressing FLAG-TrkB:A and mCherry-PTP1B Y46F/D181A substrate-trapping mutant ( Figure 3D ). The mCherry-PTP1B Y46F/D181A signal was observed close to the cell periphery ( Figures 3F and 3L ) and showed near complete overlap with peripheral ER localization in sympathetic cell bodies as marked by GFP-Sec61 expression ( Figures S1D-S1F ). In the absence of ligand, FLAG antibody-bound Trk receptors found at the cell surface showed minimal co-localization with (O-Q) Soma-surface-resident TrkA receptors are phosphorylated by NGF treatment of distal axons compared with unstimulated neurons. Cell bodies in compartmentalized cultures were biotin-labeled before stimulating distal axons with NGF (100 ng/mL, 1 hr). Cell-body lysates were subjected to neutravidin precipitation and immunoblotting using anti-P-TrkA
Y794
. P-TrkA immunoblots were stripped and reprobed for TrkA for normalization of protein amounts (P). Densitometric quantification of P-TrkA levels normalized to total TrkA (Q). Results are means ± SEM from three independent experiments and expressed relative to the unstimulated condition. **p < 0.01, t test. . **p < 0.01, t test. Results are means ± SEM from three independent experiments. Total of 45 neurons per condition were analyzed.
mCherry-PTP1B
Y46F/D181A ( Figures 3E-3J ). In contrast, significant co-localization was observed between soma-surfacederived Trk receptors and the mCherry-PTP1B Y46F/D181A signal at the cell-body perimeter in ligand-treated neurons ( Figures  3K-3Q ). We next asked if Trk-PTP1B interactions occur postendocytosis, as reported previously for PTP1B and several RTKs, including the insulin receptor, epidermal growth factor receptor, and platelet-derived growth factor receptor (Boute et al., 2003; Haj et al., 2002) . We assessed the degree of co-localization between FLAG-bound receptors and mCherry-PTP1B Y46F/D181A after stripping surface FLAG antibodies from soma membranes. Prominent co-localization was still observed, with 61% ± 2% of the FLAG signal co-localizing with mCherry fluorescence, after removal of surface-bound FLAG antibodies ( Figures S1G-S1R) , indicating association between internalized Trk receptors and PTP1B. The peripheral localization of Trk receptors in BDNFstimulated neurons ( Figures 3K and 3N ) suggests that association with the PTP1B Y46F/D181A substrate-trapping mutant likely restricts endocytosed receptors to the soma perimeter.
PTP1B Activity in Neuronal Soma Is Required for Transcytosis
To address the necessity of PTP1B for transcytosis, we monitored soma-to-axon transcytosis of FLAG-TrkB:A receptors in compartmentalized neurons treated with a cell-membranepermeable PTP1B-specific inhibitor (compound II, 200 nM) (Xie et al., 2003) , added exclusively to cell-body or axon compartments ( Figure 4A ). We confirmed that the PTP1B inhibitor suppresses the ability of PTP1B to dephosphorylate TrkA receptors ( Figures S2A and S2B) . Strikingly, selective inhibition of PTP1B in cell bodies abolished ligand-induced anterograde transcytosis of Trk receptors, whereas PTP1B inhibition in axons had no effect ( Figures 4B-4F ). Although PTP1B is expressed in sympathetic axons ( Figure S2C ), our data that axon-specific inhibition of PTP1B did not alter transcytosis suggests that axonal PTP1B activity is dispensable for the retrograde neurotrophin signaling that mediates transcytosis. Importantly, our results demonstrate that PTP1B activity is required in cell bodies to promote anterograde Trk transcytosis. In sympathetic neurons, TrkA is also dephosphorylated by the SHP family of tyrosine phosphatases (Marsh et al., 2003) . However, local application of a membrane-permeable SHP-1/2 inhibitor, NSC-87877, either to cell-body or axon compartments of sympathetic neurons did not affect ligand-induced transcytosis of Trk receptors ( Figures S2D-S2H) . Together, these results point to a specific requirement for PTP1B tyrosine phosphatase activity in mediating anterograde Trk transcytosis.
To address if the effect of PTP1B on TrkA transcytosis is direct, we sought to specifically abolish TrkA-PTP1B interactions. Thus, we generated mutant TrkA R685A receptors with a point mutation in the conserved PTP1B recognition motif (DYYR) located in the TrkA kinase activation domain ( Figure S2I ). The TrkA R685A mutation prevented receptor binding to PTP1B and suppressed PTP1B-induced TrkA dephosphorylation but did not disrupt TrkA kinase activity or downstream signaling ( Figures S2J-S2M ). We found that chimeric FLAG-TrkB:A R685A receptors, when expressed in sympathetic neurons, exhibited impaired transcytosis in response to axon-applied BDNF (Figures 4G-4K ), similar to the findings with soma-specific PTP1B inhibition. Since receptor kinase activity is unaffected by the point mutation, we reason that the mutant TrkA R685A receptors are likely to be internalized in axons and retrogradely transported. Together, these results support that specific interactions between TrkA and PTP1B and PTP1B-mediated dephosphorylation of TrkA receptors dictate anterograde transcytosis.
PTP1B Inactivation Results in Lysosomal Degradation of Soma-Surface-Derived Trk Receptors
We next addressed the cellular fate of soma-surface-derived Trk receptors that are unable to undergo axonal transcytosis upon PTP1B inactivation. One clue came from our observations that, in compartmentalized cultures, we did not observe significant intracellular accumulation of FLAG-TrkB:A receptors originating from soma surfaces upon cell-body-specific inactivation of PTP1B or expression of mutant FLAG-TrkB:A R685A receptors ( Figures 4E, 4J , S3A, and S3B). Furthermore, prolonged PTP1B inhibition (90 min) induced a pronounced downregulation of surface TrkA receptors under steady-state conditions, without altering total TrkA protein levels in mass cultures of sympathetic neurons ( Figures S3C and S3D ). Based on these results, we reasoned that surface TrkA receptors, which are phosphorylated upon PTP1B inactivation, might undergo degradation. To test this prediction, we performed FLAG antibody feeding in compartmentalized cultures to follow soma-surface-derived Trk receptors in combination with immunostaining for LAMP1, a lysosomal marker ( Figure 5A ). After BDNF stimulation of axons for 2 hr, 8.9% ± 1.4% of FLAG-TrkB:A punctae co-localized with LAMP-1 in the absence of PTP1B inhibitor, whereas in the presence of the inhibitor added to cell bodies, this co-localization was significantly increased to 31% ± 2.1% ( Figures 5B-5D ). Note that, with a shorter duration of PTP1B inhibition (2 hr), intracellular punctae for soma-surface-derived Trk receptors are still observed in cell bodies ( Figure 5C ) compared with 4 hr of inhibitor treatment ( Figure 4E ). Treatment of cell bodies with the PTP1B inhibitor also reduced co-localization of somasurface-derived Trk receptors with Rab-11 ( Figures S3E-S3G ), which marks recycling endosomes responsible for anterograde transcytosis of TrkA receptors (Ascano et al., 2009 ). Together, these results suggest that PTP1B inhibition results in the diverting of soma-surface-derived Trk receptors to lysosomes, contributing to their failure to be transported to axons. Consistent with this notion, we found that exposure of neuronal cell bodies to the PTP1B inhibitor in the presence of chloroquine, a lysosomotropic agent that prevents lysosome acidification and endosome-lysosome fusion (de Duve et al., 1974) , promoted robust intracellular accumulation of soma-surface-derived Trk receptors in cell bodies and even elicited aberrant localization of receptors in axons (Figures 5E-5K ). These results suggest that inhibition of lysosome function protects soma-surfacederived Trk receptors from a degradative fate upon PTP1B inhibition and allows the internally accumulated receptors to escape to axons.
PTP1B Deletion in Mice Decreases Axonal TrkA Levels and Impairs NGF-Mediated Trophic Functions
To assess the role of PTP1B in TrkA trafficking in vivo, we examined TrkA expression in sympathetic neuron cell bodies and nerve terminals in conditional mutant mice lacking the PTPN1 gene that encodes for PTP1B. Selective disruption of PTP1B in sympathetic neurons was accomplished by crossing mice harboring a floxed PTPN1 allele (PTPN1 f/f mice) (Bence et al., 2006) with TH-Cre transgenic mice (Gong et al., 2007) . qPCR and immunoblotting analyses of superior cervical ganglia (SCG) showed significant loss of PTP1B transcript and protein in newborn TH-CRE;PTPN1 f/f mice ( Figures S4A-S4C ). Inducible deletion of PTPN1 from compartmented cultures of PTPN1 fl/fl sympathetic neurons, using a membrane-permeable CRE recombinase (TAT-CRE), also markedly attenuated soma-toaxon Trk transcytosis, similar to the results with pharmacological inhibition of PTP1B ( Figures S4D-S4I ). We next examined TrkA protein expression in vivo in sympathetic neuron cell bodies residing in the SCG, and in the salivary glands, a target tissue that is densely innervated by sympathetic axon projections from the SCG. TrkA protein expression was reduced by $45% in salivary gland tissue with conditional PTPN1 loss, whereas TrkA levels in sympathetic ganglia were unaffected ( Figures 6A  and 6B ). The decrease in axonal TrkA expression is not a result of fewer sympathetic nerves in the target area in PTPN1-deficient mice since tyrosine hydroxylase (TH), a noradrenergic marker, was comparable between the two genotypes ( Figure 6A ). PTPN1 deletion had no effect on levels of the p75 neurotrophin receptor in sympathetic axons, suggesting a specific need for PTP1B in regulating axonal expression of TrkA receptors ( Figures S4J and S4K ). These results suggest that PTP1B is essential for anterograde transport of TrkA receptors in sympathetic axons. Mice lacking one copy of the TrkA allele have normal neuron numbers and target innervation during sympathetic nervous system development (Ghasemlou et al., 2004; Vaegter et al., 2011) . Consistent with these findings, the 45% depletion in axon TrkA levels elicited by PTP1B loss did not significantly affect sympathetic neuron viability (23,077 ± 903 neurons in TH-CRE;PTPN1 f/f mice versus 22,939 ± 1,236 in control PTPN1 f/f littermates) at postnatal day 0.5 (P0.5) ( Figures 6C, 6D , and 6G). Similarly, no deficits in target innervation were observed in newborn TH-CRE;PTPN1 f/f mice ( Figures 6H, 6I , and 6L). To unmask a potential role for PTP1B in neurotrophin-mediated functions, we asked if PTPN1 loss would exacerbate neuron deficits in NGF heterozygous mice, a scenario where sympathetic neurons are engaged in a developmental competition for sub-optimal NGF concentrations. Thus, we crossed TH-CRE;PTPN1 f/f mice with NGF heterozygous mice that have one functional copy of NGF. Consistent with previous studies reporting on the haplo-insufficiency of NGF (Brennan et al., 1999; Ghasemlou et al., 2004) , we found that loss of one NGF allele results in a significant decrease (31% reduction) in neuronal number in the P0. 
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P0.5 mice (H and I). PTPN1 loss (K) aggravates sympathetic innervation deficits in NGF +/-mice (J).
Normalized innervation density (% of PTPN1 f/f ) is shown in (L). Scale bar, 100 mm. **p < 0.01, *p < 0.05, one-way ANOVA. Results are means ± SEM from four mice per genotype.
nectivity (Yamashita and Kuruvilla, 2016) . Here, we describe a new function for signaling endosomes in instructing the soma-to-axon transcytosis of newly synthesized TrkA receptors, and we define the molecular underpinnings (Figure 7) . We show that active TrkA receptors, retrogradely transported in signaling endosomes, are inserted on soma surfaces where they elicit phosphorylation and subsequent endocytosis of naive soma-surface-resident TrkA receptors. However, the trade-off for receptor phosphorylation and internalization in cell bodies is a potential to send active receptors to axons, which would prevent new interactions with ligand at nerve terminals. We identify a gatekeeping mechanism in which TrkA receptors, destined for transcytosis, are dephosphorylated in neuronal soma by the ER-resident tyrosine phosphatase, PTP1B. TrkA-PTP1B interactions occur in a ligand-dependent manner, and PTP1B activity in soma is necessary for axonal targeting. Thus, PTP1B activity in cell bodies ensures that inactive receptors are transported to engage with target-derived NGF. In the absence of PTP1B activity, TrkA receptors internalized in cell bodies are re-routed to lysosomes for degradation. We provide in vivo evidence that PTP1B is necessary for sufficient TrkA levels in axons, and genetic interaction analyses demonstrate that PTP1B is necessary for neuron survival and axon innervation when concentrations of targetderived NGF are attenuated. Together, these results provide mechanistic insight into a positive feedback loop by which target-derived NGF recruits its own receptors to nerve terminals to amplify neuronal responsiveness.
How do retrogradely transported NGF-TrkA signaling endosomes elicit phosphorylation of naive receptors at the soma surface? A plausible mechanism is that exocytosis of retrograde signaling endosomes to soma surfaces elicits spontaneous auto-phosphorylation of soma-surface-resident Trk receptors due to local increases in receptor density and receptor clustering on membrane micro-domains (Sawano et al., 2002; Verveer et al., 2000) . It is also possible that extracellular release of NGF, co-transported in the retrograde endosomes, assists in receptor dimerization and phosphorylation. However, we reason that the majority of Trk receptors internalized from soma surfaces are likely to be un-liganded, because the amount of NGF that is retrogradely transported from axons and released from soma is not enough to be associated with the endocytosed receptors. Only $2%-2.5% of NGF bound to axon terminals undergoes retrograde transport (Tsui-Pierchala and Ginty, 1999; Ure and Campenot, 1997) , and the majority of signaling endosomes are estimated to house a single NGF dimer (Cui et al., 2007) .
A key question is how does PTP1B distinguish between somaversus axon-derived TrkA receptors? We found that PTP1B is present in axons, but axon-specific inhibition of PTP1B did not affect the ability of axon-derived Trk receptors to mediate soma-to-axon transcytosis (Figure 4) , suggesting that retrogradely transported active TrkA receptors are immune to the actions of PTP1B. It is likely that the presence of ligand in NGFTrkA-signaling endosomes ensures the continuous phosphorylation of retrogradely transported TrkA receptors. In contrast, the soma-surface-derived receptors that are un-liganded are susceptible to PTP1B-mediated dephosphorylation. Previously, PTP1B has been shown to distinguish between basally versus ligand-bound phosphorylated EGFRs (Baumdick et al., 2015) .
Previous studies have reported on other tyrosine phosphatases that attenuate basal and/or ligand-stimulated TrkA activity (Faux et al., 2007; Marsh et al., 2003; Shintani and Noda, 2008; Zhang et al., 2016) . Our findings that PTP1B enhances neuronal responsiveness to target-derived NGF emphasize that protein tyrosine phosphatases do not simply attenuate signaling responses to extracellular signals but can act as positive regulators of receptor and receptor-associated tyrosine kinase signaling. Moreover, a notable aspect of our study is the unusual mechanism by which a tyrosine phosphatase positively regulates trophic factor signaling via exerting control of the long-distance trafficking of receptors to axonal growth cones.
Our observations that conditional PTPN1 deletion in sympathetic neurons diminished axonal levels of TrkA by half without obvious impairment of neuron viability or axon growth are in agreement with previous studies of normal sympathetic neuron numbers and target innervation in mice lacking one functional allele of TrkA (Ghasemlou et al., 2004; Vaegter et al., 2011) . However, PTP1B deficiency significantly attenuated sympathetic neuron numbers and target innervation specifically under conditions of NGF haplo-insufficiency, indicating that PTP1B activity is crucial for trophic support when NGF concentrations are sub-optimal. We do not exclude the possibility that PTP1B has additional substrates in sympathetic neurons. However, the observed genetic interactions between NGF and PTPN1 argue that the sympathetic neuron phenotypes observed in 2001), are consistent with the notion that PTP1B has limited and exquisite functional specificity in vivo. A mechanism that could contribute to functional specificity is the anchorage of PTP1B to the cytosolic face of the ER that topologically restricts access to specific substrates. Our findings raise the intriguing possibility that different modes of axonal targeting are utilized during distinct stages of sympathetic nervous system development. Constitutive delivery via the direct secretory pathway might serve to deliver TrkA receptors to growing sympathetic axons during the initial phases of outgrowth from sympathetic ganglia and extension along intermediate targets, which are NGF independent (Fagan et al., 1996; Glebova and Ginty, 2004; Wickramasinghe et al., 2008) . However, when sympathetic axons reach final NGF-expressing targets, retrograde NGF signaling actively recruits the transcytosis machinery and PTP1B activity to augment anterograde delivery of TrkA receptors to gain a competitive advantage in the developmental competition for target-derived growth factor. A key question for future studies is whether regulation of the transcytosis machinery is a general mechanism for targetderived NGF to recruit additional membrane proteins necessary for axon growth and synapse maturation. Target-derived NGF is a potent trophic factor for sympathetic neurons, and it is feasible that NGF promotes the anterograde delivery of adhesion molecules, ion channels, synaptic components, and other membrane proteins co-localized in the same transcytosing vesicles as TrkA and necessary for fully functional nerve terminals. For example, the growth-promoting adhesion molecules, NgCAM and b-1-integrins, are transported to axons via transcytosis (Eva et al., 2010; Wisco et al., 2003) , although it is unknown if their transport is regulated by target-derived NGF. The role of transcytosis in axonal targeting may have implications that extend beyond early neural development to the pathogenesis of some neurodegenerative disorders. Impaired soma-toaxon transcytosis of amyloid precursor protein and low-density lipoprotein receptors observed in human iPSC-derived neurons harboring mutations in genes associated with familial Alzheimer's disease has been postulated to contribute to pathological deficits in synapse maintenance and function (Woodruff et al., 2016) . In future studies, biochemical characterization of a ''transcytosome'' and identification of specific signaling pathways and endocytic machinery will be critical to fully characterize this newly described mode of axonal targeting and will help clarify how extracellular signals regulate long-distance communication between the axon and somato-dendritic membrane domains.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: -P2A-GFP were generated by sub-cloning into pAdenoX-Tet3G using the Adeno-XTM Adenoviral System 3 kit. Recombinant adenoviral backbones were packaged into infectious adenoviral particles by transfection into HEK 293 cells using Polyethyleneimine (PEI). High-titer viral stocks were purified using a CsCl gradient.
Live-Cell Antibody Feeding Soma-to-Axon Transcytosis in Compartmentalized Cultures Live-cell antibody feeding assays to monitor Trk receptor transcytosis were performed as previously described (Ascano et al., 2009) . Sympathetic neurons were grown in compartmentalized culture chambers, assembled on collagen-coated glass coverslips for 9 days in vitro (DIV), until axonal projections were evident in the side compartments. Neurons were infected with an adenoviral vector expressing FLAG-TrkB:A chimeric receptors. Infected neurons were identified by GFP that is co-expressed with FLAG-TrkB:A using a self-cleaving P2A peptide sequence (GSGATNFSLLKQAGDVEENPGP). After withdrawing NGF from the culture media, surface chimeric receptors residing in cell body compartments were labeled under live-cell conditions with a mouse anti-FLAG antibody (1:500) in Phosphate Buffered Saline (PBS) for 30 minutes at 4 C. Excess antibody was washed off and cultures were pre-treated with various pharmacological inhibitors locally applied to axon compartments (1NMPP1, U73122, FK506 + Cyclosporin A, Dynasore, PTP1B inhibitor, or NSC-87877) or to cell body compartments (PTP1B inhibitor, NSC-87877, or PTP1B inhibitor + Chloroquine) at 37 C for 30 minutes, followed by stimulation with BDNF (100 ng/ml) added to axon compartments for 4 hr. Neurons were then washed quickly with PBS, fixed with 4% paraformaldehye (PFA) in PBS for 30 minutes at room temperature, permeabilized with 0.1% Triton X-100/5% normal goat serum/PBS and incubated with anti-mouse Alexa-546 secondary antibody (1:1000; ThermoFisher) for 2 hr, followed by mounting on slides with Fluoromount Aqueous Mounting Medium (Sigma) containing 100 mg/ml DAPI.
Cell body images were acquired using a Zeiss AxioImager Z1 imaging microscope with Hamamatsu Orca Flash 4.0 CMOS camera and Apotome 2. The same acquisition settings were applied to all images taken from a single experiment. Cell bodies were analyzed by using ZEN 2012 (blue edition) software. Intracellular accumulation of chimeric receptors in cell bodies were quantified as the number of FLAG-immunopositive punctae per neuron. Cell bodies were visualized using the GFP signal and FLAG signals overlapping with GFP fluorescence were defined as internalized soma surface-derived receptors. For all imaging, 15 cell bodies were analyzed per condition per experiment. Results are expressed as means ± SEM and expressed relative to the ''no ligand'' condition.
Axon-derived Trk receptors exocytosed to soma surfaces were quantified as the number of FLAG-immunopositive punctae per soma. 20 neurons were analyzed per condition per experiment. Axon images representing 0.8 mm optical slices were acquired using a Zeiss LSM 700 confocal scanning microscope with 405, 488, and 555nm lasers. The same confocal acquisition settings were applied to all images taken from a single experiment. Axons were analyzed by taking z-stacks and creating a 3-dimensional reconstruction using ZEN 2012 SP1 (black edition) software. Transcytosed chimeric receptors in axons were quantified as the number of FLAG-immunopositive punctae per square micrometer of distal axons. Axons were visualized using the GFP signal and measurements were taken from a stretch of axons 100 mm from the axon tip. For all imaging, 20 axons were analyzed per condition per experiment. Results are expressed as means ± SEM and expressed relative to the ''no ligand'' condition. Exocytosis of Axon-Derived Trk Receptors in Soma Chimeric FLAG-TrkB:A receptors in distal axon compartments of compartmentalized cultures were live-labeled with a mouse anti-FLAG antibody (1:500). Excess antibody was washed off, and axons were treated with BDNF (100 ng/ml, 1 hr, 37 C) or left un-stimulated. Neurons were fixed, and incubated with anti-mouse Alexa-546 secondary antibody without permeabilization. Images were acquired using a Zeiss AxioImager Z1 imaging microscope with Hamamatsu Orca Flash 4.0 CMOS camera and Apotome 2. The same acquisition settings were applied to all images taken from a single experiment. Axon-derived Trk receptors exocytosed to soma surfaces were quantified as the number of FLAG-immunopositive punctae per soma. 20 neurons were analyzed per condition per experiment. Dual Color Antibody Feeding Assay Surface chimeric receptors residing in distal axon and cell body compartments were live-labeled with a mouse anti-FLAG antibody (1:500) and a rabbit anti-FLAG antibody (1:100), respectively. Excess antibodies were washed off and axons were stimulated with BDNF (100 ng/ml, 1 hr, 37 C) or left un-stimulated. Neurons were fixed, permeabilized using 0.1% Triton X-100/5% normal goat serum/PBS, and incubated with anti-mouse Alexa-546 and anti-rabbit Alexa-350 secondary antibodies. Images were acquired using a Zeiss AxioImager Z1 imaging microscope with Hamamatsu Orca Flash 4.0 CMOS camera and Apotome 2. Co-localization of axon and soma surface-derived Trk receptors were quantified as the number of punctae double-positive for Alexa-350 and Alexa-546 and expressed as a percentage of the Alexa-350-positive punctae in soma (total Trk receptors derived from soma surfaces). To investigate the interactions between axon and soma surface-derived Trk receptors, neurons were fixed, permeabilized, and Neuronal Cell Counts P0.5 mouse torsos were fixed in PBS containing 4% PFA, and then cryoprotected in 30% sucrose-PBS. SCG sections (12 mm) were stained with a solution containing 0.5% cresyl violet (Nissl). Cells with characteristic neuronal morphology and visible nucleoli were counted in every fifth Nissl-stained section.
Immunohistochemistry P0.5 mouse sections (12 mm) were washed in PBS, permeabilized in PBS containing 0.1% Triton X-100, and blocked using 5% goat serum in PBS + 0.1% Triton X-100. Sections were then incubated with a rabbit anti-TH antibody (1:200) overnight. Following PBS washes, sections were incubated with anti-rabbit Alexa-488 secondary antibody (1:200; ThermoFisher). Sections were then washed in PBS and mounted in Fluoromount Aqueous Mounting Medium containing 100 mg/ml DAPI. Images representing 1.8 mm optical slices were acquired using a Zeiss LSM 700 confocal scanning microscope with 405, 488. The same confocal acquisition settings were applied to all images taken from a single experiment. Quantification of sympathetic innervation density in the salivary glands was done by calculating integrated TH fluorescence density per unit area (ImageJ) from multiple random images.
RT-PCR Analyses
Total RNA was prepared from dissected SCG using RNeasy mini purification kit (QIAGEN). RNA was then reverse transcribed using a M-MLV Reverse Transcriptase (Promega). Real-time qPCR was performed using a Maxima SYBR Green/Rox Q-PCR Master Mix (ThermoFisher), in a StepOnePlus Real-Time PCR Systems (ThermoFisher). PTP1B mRNA (NM_011201.3) levels were measured by using primers targeting nucleotides 701-890. GAPDH was used as a control. Each sample was analyzed in triplicate reactions. Fold change in PTP1B transcript levels was calculated using the 2 (-DDCt) method, normalizing to GAPDH transcript.
QUANTIFICATION AND STATISTICAL ANALYSIS
Sample sizes were similar to those reported in previous publications (Ascano et al., 2009; Bodmer et al., 2011; Patel et al., 2015) . Data were collected randomly. For practical reasons, analyses of neuronal cell counts and axon innervation in mouse tissues were done in a semi-blinded manner such that the investigator was aware of the genotypes prior to the experiment, but conducted the staining and data analyses without knowing the genotypes of each sample. All Student's t tests were performed assuming Gaussian distribution, two-tailed, unpaired, and a confidence interval of 95%. One-way or two-way ANOVA analyses with post hoc Tukey test were performed when more than two groups were compared. Statistical analyses were based on at least 3 independent experiments, and described in the figure legends. All error bars represent the standard error of the mean (s.e.m).
